Share prices for Amityville-based drugmaker Hi-Tech Pharmacal have been surging through the trading day on news of a $1.9 billion buyout within the pharmaceutical industry. Hi-Tech's stock is up over ...
Co announces the FDA granted tentative approval to the co's Abbreviated New Drug Application for Calcipotriene topical solution, 0.005%. Hi-Tech's Calcipotriene topical solution is the generic ...
Co announces it entered into a settlement and release agreement regarding the patent infringement suit brought by MedPointe Pharmaceuticals related to Hi-Tech's generic version of Tussi-12 DS, covered ...
The two sides reviewed potential joint ventures between Egyptian and Indian pharmaceutical companies, particularly in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback